MI-217
MI-217 is a potent SIRT3 inhibitor. MI-217 induces MDA-MB-231 apoptosis. MI-217 can be used in the study of breast cancer[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; Sirtuin
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mi-217.html
Smiles
S=C(N/N=C/C1=CC=C([N+]([O-])=O)C=C1)NCC
Molecular Formula
C10H12N4O2S
Molecular Weight
252.29
References & Citations
[1]Ullah A, et al. Identification of small molecular inhibitors of SIRT3 by computational and biochemical approaches a potential target of breast cancer. Sci Rep. 2024 May 30;14 (1) :12475.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6401570-01 0.1 mL
P2RX7 (P2X Purinoceptor 7, P2X7, ATP Receptor, P2Z Receptor, Purinergic Receptor, MGC20089) (PE)
Ask
View Details MBS6401570-02 5x 0.1 mL
P2RX7 (P2X Purinoceptor 7, P2X7, ATP Receptor, P2Z Receptor, Purinergic Receptor, MGC20089) (PE)
Ask
View Details